Earnings Releases·Nov 10, 2026, 4:06 PM ET

QT Imaging — Q3 2026 Earnings Summary

Q3 2026 revenue rose 75% year-over-year to $7.3 million, while net loss narrowed significantly to $0.3 million ($0.02/share) from $4.6 million in the prior year, a result driven by a $2.4 million noncash gain from earnout liability revaluation.
Full-year 2026 revenue guidance was revised downward to approximately $34 million from $39 million due to shipment delays in Saudi Arabia and the UAE caused by Middle East conflict and Strait of Hormuz closures, though U.S. shipments remain on schedule.
CMS established a separate Medicare payment pathway for QTscan examinations effective January 1, 2027, and the company secured a national group purchasing agreement via NXC Imaging, granting access to nearly 4,400 hospitals.
The company completed a facility relocation in Petaluma, California, doubling manufacturing capacity, and advanced its Breast Acoustic CT platform with new image reconstruction and cloud capabilities.
Long-term debt increased to $11.4 million following a loan modification extending maturity to March 2029 at a 12% interest rate, which contributed to an $8.3 million loss on debt extinguishment over the nine-month period.